Key result
Alarin improves cardiac function in a rat HFpEF model by alleviating oxidative stress.
Why the study?
Heart failure with preserved ejection fraction is increasingly prevalent and poses significant treatment challenges, motivating investigation into the potential mechanisms of alarin in protecting cardiac function.
Answers are grounded in this paper and cite their sources.
Oxidative stress may be targetable in HFpEF; animal data leave open alarin's clinical translation.
Heart failure with preserved ejection fraction (HFpEF), a complex disease that is increasingly prevalent due to population aging, pose significant challenges in its treatment. The present study utilized the HFpEF rat model and H9C2 cells as research subjects to thoroughly investigate the potential mechanisms of alarin in protecting cardiac function in HFpEF. The study shows that under HFpEF conditions, oxidative stress significantly increases, leading to myocardial structural damage and dysfunction of calcium ion channels, which ultimately impairs diastolic function. Alarin, through its interaction with NADPH oxidase 1 (NOX1), effectively alleviates oxidative stress and modulates the activities of type 2 ryanodine receptor (RyR2) and sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2), thereby facilitating the restoration of Ca2+ homeostasis and significantly improving cardiac function in the HFpEF model. This research not only uncovers the cardioprotective effects of alarin and its underlying molecular mechanisms but also provides new insights and potential therapeutic targets for HFpEF treatment strategies, suggesting a promising future for alarin and related therapies in the management of this debilitating condition.
No takes yet. Share an insight, caveat, or question.
Li et al. (2024) studied Heart failure with preserved ejection fraction (HFpEF). Alarin vs. Saline (HSD model group) was evaluated on Ejection fraction (EF) index (p=0.0006). Alarin significantly improved cardiac function, including ejection fraction (p=0.0006), in a rat model of heart failure with preserved ejection fraction by alleviating oxidative stress.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: